Jeffrey Moore
Director/Board Member at MP Healthcare Venture Management, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hannah Fiona Sore | M | 47 |
Pharmenable Ltd.
 Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | 8 years |
| Natalia Mateu | M | 41 |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | 8 years |
| Keizo Koya | M | 66 |
SOLA Biosciences LLC
 SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | 8 years |
| Jelena Aleksic | M | - |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | 8 years |
| David Spring | M | - |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | 8 years |
| Andreas Bender | M | - |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | 8 years |
| Akinori Hishiya | M | - |
SOLA Biosciences LLC
SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | - |
| Jane Elizabeth Dancer | M | 61 |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | - |
| Roel Bulthuis | M | - |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 4 years |
| John Bial | M | - |
Capsigen, Inc.
 Capsigen, Inc. BiotechnologyHealth Technology Capsigen, Inc. is a company based in Vancouver, WA that is developing the next generation of AAV vectors for gene therapy. The company's end-to-end platform uses customized, diverse libraries and proprietary trade™ technology to identify fully functional vectors that meet disease-specific transduction criteria. Capsigen's fit-for-purpose vectors are designed to deliver the highest level of clinical utility in a rapid and high-throughput manner. The company uses data science and directed evolution to build custom AAV capsids to move patients from hope to cured. John Bial has been the CEO of the company since 2020. | 4 years |
| Christine Martin | M | - |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | 4 years |
| Gaynor Mary Fryers | F | 67 |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | - |
| Shota Ozawa | M | - |
MP Healthcare Venture Management, Inc.
 MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jason Evans | M | - |
University of Oxford
| 9 years |
| Junichi Watanabe | M | - |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | 1 years |
| Akira Shimosakon | M | - |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | - |
| Takashi Nagao | M | - |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | 9 years |
| Gregg Robins | M | - |
University of Oxford
| 7 years |
| Antony J. Fairbanks | M | - |
University of Oxford
| 3 years |
| Nigel L. Clarke | M | - |
University of Oxford
| 4 years |
| Ick-Soo Kim | M | 68 |
University of Oxford
| 3 years |
| Reid Hoffman | M | 56 |
University of Oxford
| 8 years |
| Doron Junger | M | - |
University of Oxford
| 6 years |
| Mark Carney | M | 59 |
University of Oxford
| 3 years |
| Kathryn Farrar | F | 47 |
University of Oxford
| 5 years |
| Philip Shapiro | M | 49 |
University of Oxford
| 3 years |
| William Ashby | M | - |
University of Oxford
| 4 years |
| Man Wai Chiu | M | 55 |
University of Oxford
| 5 years |
| Girindre Beeharry | M | - |
University of Oxford
| 2 years |
| Argyris Stasinakis | M | - |
University of Oxford
| 8 years |
| Simon H. Thomas | M | 64 |
University of Oxford
| 5 years |
| Byron Auguste | M | 56 |
University of Oxford
| 4 years |
| Naoya Sato | M | - |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | 4 years |
| Michael Hewett | M | - |
University of Oxford
| 7 years |
| Yu Leng Khor | M | 53 |
University of Oxford
| 4 years |
| David C. Parkes | M | - |
University of Oxford
| 1 years |
| James Heath | M | - |
University of Oxford
| 5 years |
| Christopher Graham Parkin | M | 51 |
University of Oxford
| 4 years |
| Sarah Pearson | F | - |
University of Oxford
| 3 years |
| Yau Hool | M | - |
University of Oxford
| 4 years |
| Francesca Jane McDonagh | F | 48 |
University of Oxford
| 4 years |
| Javier Santiso Guimaras | M | 55 |
University of Oxford
| 3 years |
| Nailesh Rambhai | M | - |
University of Oxford
| 3 years |
| Richard Sanders | M | 48 |
University of Oxford
| 3 years |
| Harry Seekings | M | 51 |
University of Oxford
| 3 years |
| Maria Teresa H. D. S. M. Roque Dal Fabbro | F | - |
University of Oxford
| 3 years |
| Bader Abdulmohsen Nassir El-Jeaan | M | - |
University of Oxford
| 4 years |
| Paul Woodman | M | - |
University of Oxford
| 4 years |
| Azrina binti Raja Abdul Aziz | F | 51 |
University of Oxford
| 4 years |
| Tom Reusch | M | - |
University of Oxford
| 3 years |
| Nick Richards | M | - |
University of Oxford
| 4 years |
| Hossein Ghodse | M | - |
University of Oxford
| 4 years |
| Andrew Priest | M | - |
University of Oxford
| 3 years |
| MICHAEL DAL BELLO | M | - |
University of Oxford
| 2 years |
| Darren Scott Cockburn | M | 55 |
University of Oxford
| 3 years |
| Ian Gardiner | M | - |
University of Oxford
| 4 years |
| Angela Duckworth | M | - |
University of Oxford
| 2 years |
| Tak Chi Woo Chan | F | 48 |
University of Oxford
| 4 years |
| Chee Peng Ng | M | 54 |
University of Oxford
| 4 years |
| Ranu Dayal | M | - |
University of Oxford
| 4 years |
| Johnny Carew Pole | M | - |
University of Oxford
| 3 years |
| Jason Gardner | M | 53 |
University of Oxford
| 4 years |
| Mark Andrew Urquhart | M | - |
University of Oxford
| 4 years |
| Mark Brooker | M | 52 |
University of Oxford
| 4 years |
| Gerald Cardinale | M | 56 |
University of Oxford
| 2 years |
| Nicola Broughton | M | - |
University of Oxford
| - |
| Chong Toh | M | 55 |
University of Oxford
| 4 years |
| Han Choi | M | - |
University of Oxford
| 2 years |
| Peter Flint | M | 49 |
University of Oxford
| 4 years |
| Richard A. Hull | M | - |
University of Oxford
| 3 years |
| Timothy R. J. Stubbs | M | 56 |
University of Oxford
| 4 years |
| Christopher Hole | M | - |
University of Oxford
| 1 years |
| Alan Jonathan Dodsworth | M | - |
University of Oxford
| 4 years |
| Mark Gallagher | M | - |
University of Oxford
| 4 years |
| Simon Munton Bullivant | M | - |
University of Oxford
| 4 years |
| Duncan R. Reid-Thomas | M | - |
University of Oxford
| 4 years |
| Gary Jacob | M | 77 |
University of Oxford
| 4 years |
| Zachary Karabell | M | - |
University of Oxford
| 2 years |
| Julian Richard Mackay Wellesley | M | - |
University of Oxford
| 4 years |
| Nicholas Stiggers | M | - |
University of Oxford
| 3 years |
| Chris Gradel | M | 51 |
University of Oxford
| 1 years |
| Paul Markovich | M | - |
University of Oxford
| 2 years |
| Paul Geddes | M | 55 |
University of Oxford
| 4 years |
| Jonathan Montagu | M | - |
University of Oxford
| 5 years |
| Natalia Gurushina | M | - |
University of Oxford
| 5 years |
| Chor Shan Lai | F | 51 |
University of Oxford
| 3 years |
| Dave Geary | M | - |
University of Oxford
| 1 years |
| Jeong-Hun Lee | M | 62 |
University of Oxford
| 3 years |
| Nick Good | M | - |
University of Oxford
| 4 years |
| Christa Ehmann Powers | M | - |
University of Oxford
| 1 years |
| Neill Penney | M | - |
University of Oxford
| 4 years |
| Tom Skinner | M | - |
University of Oxford
| 3 years |
| Natalie Cade | F | - |
University of Oxford
| 1 years |
| Tim Spence | M | - |
University of Oxford
| 3 years |
| Christopher Robert Eskdale | M | 54 |
University of Oxford
| 1 years |
| Benjamin C. Perry | M | - |
University of Oxford
| 1 years |
| Colin Jamie Brammer | M | - |
University of Oxford
| 3 years |
| Thomas Casdagli | M | 47 |
University of Oxford
| 4 years |
| Eduardo Bruno Martins | M | 61 |
University of Oxford
| 3 years |
| Bob Dowson | M | - |
University of Oxford
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 91 | 91.00% |
| United States | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeffrey Moore
- Personal Network
